These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4112641)

  • 21. On the specificity of antibodies.
    Richards FF; Konigsberg WH; Rosenstein RW; Varga JM
    Science; 1975 Jan; 187(4172):130-7. PubMed ID: 46122
    [No Abstract]   [Full Text] [Related]  

  • 22. Contact regions for dinitrophenyl and menadione haptens in an immunoglobulin binding more than one antigen.
    Rosenstein RW; Musson RA; Armstrong MK; Konigsberg WH; Richards FF
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):877-81. PubMed ID: 4112641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The strange cross-reaction of menadione (vitamin K3) and 2,4-dinitrophenyl ligands with a myeloma protein and some conventional antibodies.
    Michaelides MC; Eisen HN
    J Exp Med; 1974 Sep; 140(3):687-702. PubMed ID: 4138007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies with multiple binding functions. Induction of single immunoglobin species by structurally dissimilar haptens.
    Varga JM; Konigsberg WH; Richards FF
    Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3269-74. PubMed ID: 4131746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phylogeny of immunoglobulin structure and function. V. Valences and association constants of teleost antibodies to a haptenic determinant.
    Clem LW; Small PA
    J Exp Med; 1970 Sep; 132(3):385-400. PubMed ID: 4109109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resonance Raman-spectroscopic studies of the hapten features involved in the binding of 2,4-dinitrophenyl haptens by the mouse myeloma proteins MOPC 315 and MOPC 460.
    Kumar K; Phelps DJ; Carey PR; Young NM
    Biochem J; 1978 Nov; 175(2):727-35. PubMed ID: 743221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of 2,4-dinitrophenyl derivatives by the light chain dimer obtained from immunoglobulin A produced by MOPC-315 mouse myeloma.
    Schechter I; Ziv E
    Biochemistry; 1976 Jun; 15(13):2785-90. PubMed ID: 820373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RECOVERY OF SPECIFIC ACTIVITY AFTER COMPLETE UNFOLDING AND REDUCTION OF AN ANTIBODY FRAGMENT.
    WHITNEY PL; TANFORD C
    Proc Natl Acad Sci U S A; 1965 Mar; 53(3):524-32. PubMed ID: 14338230
    [No Abstract]   [Full Text] [Related]  

  • 29. RECOVERY OF ANTIGENIC SPECIFICITY AFTER DENATURATION AND COMPLETE REDUCTION OF DISULFIDES IN A PAPAIN FRAGMENT OF ANTIBODY.
    HABER E
    Proc Natl Acad Sci U S A; 1964 Oct; 52(4):1099-106. PubMed ID: 14224389
    [No Abstract]   [Full Text] [Related]  

  • 30. VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.
    EISEN HN; SISKIND GW
    Biochemistry; 1964 Jul; 3():996-1008. PubMed ID: 14214095
    [No Abstract]   [Full Text] [Related]  

  • 31. Tissue sulfhydryl groups.
    ELLMAN GL
    Arch Biochem Biophys; 1959 May; 82(1):70-7. PubMed ID: 13650640
    [No Abstract]   [Full Text] [Related]  

  • 32. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.
    Weber K; Osborn M
    J Biol Chem; 1969 Aug; 244(16):4406-12. PubMed ID: 5806584
    [No Abstract]   [Full Text] [Related]  

  • 33. Myeloma proteins with anti-hapten antibody activity: epsilon-2,4-dinitrophenyl lysine binding by the protein produced by mouse plasmacytoma MOPC-460.
    Jaffe BM; Eisen HN; Simms ES; Potter M
    J Immunol; 1969 Oct; 103(4):872-4. PubMed ID: 5349739
    [No Abstract]   [Full Text] [Related]  

  • 34. The nature of an antigenic determinant.
    Kabat EA
    J Immunol; 1966 Jul; 97(1):1-11. PubMed ID: 5332005
    [No Abstract]   [Full Text] [Related]  

  • 35. Specificity and structure of the myeloma protein produced by mouse plasmacytoma MOPC-460.
    Jaffe BM; Simms ES; Eisen HN
    Biochemistry; 1971 Apr; 10(9):1693-9. PubMed ID: 4996812
    [No Abstract]   [Full Text] [Related]  

  • 36. Implications of X-ray crystallographic studies of protein structure.
    Stryer L
    Annu Rev Biochem; 1968; 37():25-50. PubMed ID: 4970634
    [No Abstract]   [Full Text] [Related]  

  • 37. Cell selection by antigen in the immune response.
    Siskind GW; Benacerraf B
    Adv Immunol; 1969; 10():1-50. PubMed ID: 4900673
    [No Abstract]   [Full Text] [Related]  

  • 38. Hydrophobic binding sites on immunoglobulins.
    Parker CW; Osterland CK
    Biochemistry; 1970 Mar; 9(5):1074-82. PubMed ID: 4190691
    [No Abstract]   [Full Text] [Related]  

  • 39. Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315.
    Eisen HN; Simms ES; Potter M
    Biochemistry; 1968 Nov; 7(11):4126-34. PubMed ID: 4177521
    [No Abstract]   [Full Text] [Related]  

  • 40. Mouse myelomas producing precipitating antibody to nucleic acid bases and-or nitrophenyl derivatives.
    Schubert D; Jobe A; Cohn M
    Nature; 1968 Nov; 220(5170):882-5. PubMed ID: 4177513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.